Search Results
Search for other papers by Markus Eszlinger in
Google Scholar
PubMed
Search for other papers by Alexandra Stephenson in
Google Scholar
PubMed
Search for other papers by Shideh Mirhadi in
Google Scholar
PubMed
Search for other papers by Konrad Patyra in
Google Scholar
PubMed
Search for other papers by Michael F Moran in
Google Scholar
PubMed
Search for other papers by Moosa Khalil in
Google Scholar
PubMed
Department of Pediatrics, Turku University Hospital, Turku, Finland
Search for other papers by Jukka Kero in
Google Scholar
PubMed
Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Heritage Medical Research Building, Calgary, Alberta, Canada
Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada
Department of Medicine, Cumming School of Medicine, University of Calgary, Heritage Medical Research Building, Calgary, Alberta, Canada
Search for other papers by Ralf Paschke in
Google Scholar
PubMed
by TSHR and sex. (D) Relative intensities of thyroglobulin phosphosites To identify these baseline sex differences, the phosphorylation patterns of phosphopeptides of WT males and females were compared to one another. Significantly different
Department of Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Joachim N Nilsson in
Google Scholar
PubMed
Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
Search for other papers by Jonathan Siikanen in
Google Scholar
PubMed
Search for other papers by Vincenzo Condello in
Google Scholar
PubMed
Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Kenbugul Jatta in
Google Scholar
PubMed
Search for other papers by Ravi Saini in
Google Scholar
PubMed
Stockholms Sjukhem Foundation's Research and Development Department, Stockholm, Sweden
Department of Clinical Sciences Lund, Lund University, Lund, Sweden
Search for other papers by Christel Hedman in
Google Scholar
PubMed
Department of Breast, Endocrine Tumours and Sarcoma, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by Catharina Ihre Lundgren in
Google Scholar
PubMed
Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden
Search for other papers by C Christofer Juhlin in
Google Scholar
PubMed
(Goldfeld-Quandt test P = 0.72). Removing most variables from the model caused a significant drop in adjusted R 2 , but the model was found to perform similarly well (adjusted R 2 of 0.66) if TERT promoter mutation was replaced with thyroglobulin
Search for other papers by Hélène Théodon in
Google Scholar
PubMed
Search for other papers by Erell Guillerm in
Google Scholar
PubMed
Search for other papers by Johanna Wassermann in
Google Scholar
PubMed
Search for other papers by Gabrielle Deniziaut in
Google Scholar
PubMed
Search for other papers by Loïc Jaffrelot in
Google Scholar
PubMed
Search for other papers by Jérome Denis in
Google Scholar
PubMed
Search for other papers by Nathalie Chereau in
Google Scholar
PubMed
Search for other papers by Claude Bigorgne in
Google Scholar
PubMed
Search for other papers by Wiame Potonnier in
Google Scholar
PubMed
Search for other papers by Florence Coulet in
Google Scholar
PubMed
Search for other papers by Laurence Leenhardt in
Google Scholar
PubMed
Search for other papers by Camille Buffet in
Google Scholar
PubMed
). Metastatic neck lymph node or mass was defined by the presence of metastatic cells in the cytology report and/or with an elevated concentration of the in situ thyroglobulin (TG) >10 µg/L or calcitonin >2000 ng/L. Figure 1 Flowchart of the sample